Invention Grant
- Patent Title: Azaindole compounds as histone methyltransferase inhibitors
-
Application No.: US16002408Application Date: 2018-06-07
-
Publication No.: US11111243B2Publication Date: 2021-09-07
- Inventor: Chul Yu , Ming Yu , Manuel Zancanella , Zhe Li
- Applicant: GLOBAL BLOOD THERAPEUTICS, INC.
- Applicant Address: US CA South San Francisco
- Assignee: GLOBAL BLOOD THERAPEUTICS, INC.
- Current Assignee: GLOBAL BLOOD THERAPEUTICS, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Alston & Bird LLP
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P7/00 ; C07D519/00 ; C07D487/04

Abstract:
The present disclosure provides certain angular tricyclic compounds that are histone methyltransferases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers and hemoglobinopathies (e.g., beta-thalassemia and sickle cell disease). Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Public/Granted literature
- US20180354947A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS Public/Granted day:2018-12-13
Information query